Skip to main content
Log in

Effects of trazodone treatment on alpha-2 adrenoceptor function in depressed patients

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Tricyclic antidepressant drugs reduce the sensitivity of α2 adrenoceptors during long-term treatment. In the present study, the α2 adrenergic agonist clonidine was administered to 11 depressed patients before and during treatment with the triazolopyridine antidepressant trazodone (TRZ). Clonidine's ability to decrease blood pressure (BP) and plasma levels of the norepinephrine metabolite 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG), and to increase sedation and plasma growth hormone (GH), were measured. TRZ had little effect on these indices of pre- and postsynaptic α2 receptor function, suggesting that the antidepressant properties of TRZ are not related to changes in α2 adrenoceptor sensitivity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Al-Yassiri MM, Ankier SI, Bridges PK (1981) Minireview. Trazodone — A new antidepressant. Life Sci 28:2449–2458

    Google Scholar 

  • Anden NE, Grobowski M, Strombom U (1976) Different alpha-adrenoceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents. Naunyn-Schmiedberg's Arch Pharmacol 292:43–52

    Google Scholar 

  • Baran L, Maj J, Rogoz Z, Skuza G (1979) On the central antiserotonin action of trazodone. Pol J Pharmacol Pharm 31:25–33

    Google Scholar 

  • Blombery P, Kopin IJ, Gordon EK, Markey SP, Ebert M (1980) Conversion of MHPG to vanillylmandelic acid: Implications for the importance of urinary MHPG. Arch Gen Psychiatry 37:1095–1098

    Google Scholar 

  • Bousquet P, Schwartz J (1983) Alpha-adrenergic drugs: Pharmacological tools for the study of the central vasomotor control. Biochem Pharmacol 32(9):1459–1465

    Google Scholar 

  • Brogden RN, Heel RC, Speight TM, Avery GS (1981) Trazodone: A review of its pharmacological properties and therapeutic use in depression and anxiety. Drugs 21:401–429

    Google Scholar 

  • Cedarbaum JM, Aghajanian GK (1977) Catecholamine receptors on locus coeruleus neurons: Pharmacological characterization. Eur J Pharmacol 44:375–385

    Google Scholar 

  • Cella SG, Picotti GB, Muller EE (1983) α2-Adrenergic stimulation enhances growth hormone secretion in the dog: A presynaptic mechanism? Life Sci 32:2785–2792

    Google Scholar 

  • Cervo L, Ballabio M, Caccia S, Samanin R (1981) Blockade by trazodone of naloxone-precipitated jumping in morphine-dependent rats: Correlation with brain levels of m-chlorophenyl-piperazine. J Pharm Pharmacol 33:813–814

    Google Scholar 

  • Charney DS, Heninger GR, Sternberg DE, Hafstad KM, Giddings S, Landis DH (1982a) Adrenergic receptor sensitivity in depression: Effects of clonidine in depressed patients and healthy subjects. Arch Gen Psychiatry 39:290–294

    Google Scholar 

  • Charney DS, Heninger GR, Sternberg DE (1982b) Failure of chronic antidepressant treatment to alter growth hormone response to clonidine. Psychiatr Res 7:135–138

    Google Scholar 

  • Charney DS, Heninger GR, Sternberg GR (1982c) Assessment of alpha-2 adrenergic autoreceptor function in humans: Effects of oral yohimbine. Life Sci 30:2033–2041

    Google Scholar 

  • Charney DS, Heninger GR, Sternberg DE (1983) Alpha-2 adrenergic receptor sensitivity and the mechanism of action of antidepressant therapy: The effect of long-term amitriptyline treatment. Br J Psychiatry 142:265–275

    Google Scholar 

  • Charney DS, Heninger GR, Sternberg DE (1984) The effect of mianserin on alpha-2 adrenergic receptor function in depressed patients. Br J Psychiatry 144:407–416

    Google Scholar 

  • Charney DS, Menkes DB, Heninger GR (1981a) Receptor sensitivity and the mechanism of action of antidepressant treatment: Implications for the etiology and therapy of depression. Arch Gen Psychiatry 38:1160–1180

    Google Scholar 

  • Charney DS, Heninger GR, Sternberg DE, Redmond DE Jr, Leckman JF, Maas JW, Roth RH (1981b) Presynaptic adrenergic receptor sensitivity in depression: The effect of long-term desipramine treatment. Arch Gen Psychiatry 38:1334–1340

    Google Scholar 

  • Checkley SA, Slade AP, Shur E, Dawling S (1981a) Growth hormone and other responses to clonidine in patients with endogenous depression. Br J Psychiatry 138:51–55

    Google Scholar 

  • Checkley SA, Slade AP, Shur E, Dawling S (1981b) A pilot study of the mechanism of action of desipramine. Br J Psychiatry 138:248–251

    Google Scholar 

  • Chesselet M-F (1984) Presynaptic regulation of neurotransmitter release in the brain: Facts and hypothesis. Neuroscience 12(2):347–375

    Google Scholar 

  • Cioli V, Corradino C, Piccinelli D, Rocchi MG, Valeri R (1984) A comparative pharmacological study of trazodone, etoperidone and 1-(m-chlorophenyl)piperazine. Pharmacol Res Commun 16(1):85–100

    Google Scholar 

  • Clements-Jewery S (1978) The development of cortical β-adrenoceptor subsensitivity in the rat by chronic treatment with trazodone, doxepin and mianserine. Neuropharmacology 17:779–781

    Google Scholar 

  • Clements-Jewery S, Robson PA, Chidley LJ (1980) Biochemical investigations into the mode of action of trazodone. Neuropharmacology 19:1165–1173

    Google Scholar 

  • Cooper JR, Bloom FE, Roth RH (1982) The biochemical basis of neuropharmacology, 4th ed., New York, Oxford University Press

    Google Scholar 

  • Corn TH, Thompson C, Checkley SA (1984) Effects of desipramine treatment upon central adrenoceptor function in normal subjects. Br J Psychiatry 145:139–145

    Google Scholar 

  • Dekirmenjian H, Maas JW (1974) 3-Methoxy-4-hydroxyphenylethyleneglycol in plasma. Clin Chim Acta 52:203–210

    Google Scholar 

  • Dixon WJ, Massey FJ Jr (1969) Introduction to statistical analysis. New York, McGraw-Hill

    Google Scholar 

  • Dowdall M, deMontigny C (1984) Pre- and postsynaptic effects of trazodone on serotonin neurotransmission: Single-cell studies in the rat. Abstr Soc Neurosci 10(1):17

    Google Scholar 

  • Elsworth JD, Redmond DE, Roth RH (1982) Plasma and cerebrospinal fluid 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) as indices of brain norepinephrine metabolism in primates. Brain Res 235:115–124

    Google Scholar 

  • Enna SJ, Kendall DA (1981) Interaction of antidepressants with brain neurotransmitter receptors. J Clin Psychopharmacol, 1 [Suppl]:12S-16S

    Google Scholar 

  • Faroum F, Mayer-Schwing J, Potkin SG, Wyatt RJ (1977) Presence of free sulfate and glucuronide conjugated MHPG in human brain, cerebrospinal fluid, and plasma. Brain Res 125:333–339

    Google Scholar 

  • Fuller RW, Snoddy HD, Cohen ML (1984) Interactions of trazodone with serotonin neurons and receptors. Neuropharmacology 23(5):539–544

    Google Scholar 

  • Glass IB, Checkley SA, Shur E, Dawling S (1982) The effect of desipramine on central adrenergic function in depressed patients. Br J Psychiatry 141:372–376

    Google Scholar 

  • Gundert-Remy U, Aman E, Hildebrandt R, Weber E (1983) Lack of interaction between the tetracyclic antidepressant maprotiline and the centrally acting antihypertensive drug clonidine. Eur J Clin Pharmacol 25(5):595–599

    Google Scholar 

  • Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62

    CAS  PubMed  Google Scholar 

  • Healy D, Carney PA, Leonard BE (1982) Monoamine-related markers of depression: Changes following treatment. J Psychiatr Res 17(3):251–260

    Google Scholar 

  • Healy D, Carney PA, Leonard BE (1984) Biochemical correlates of antidepressant response: Results of a trazodone versus amitriptyline trial. Psychopathology 17 [Suppl 2]:82–87

    Google Scholar 

  • Hingtgen JN, Hendrie HC, Aprison MH (1984) Postsynaptic serotonergic blockade following chronic antidepressive treatment with trazodone in an animal model of depression. Pharmacol Biochem Behav 20:425–428

    Google Scholar 

  • Jimerson DC, Ballenger JD, Lake CR, Post RM, Goodwin FK, Kopin IJ (1981) Plasma and CSF MHPG in normals. Psychopharmacol Bull 17:86–87

    Google Scholar 

  • Koe BK (1976) Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther 199:649–661

    Google Scholar 

  • Kopin IJ, Jimerson DC, Markey SP, Ebert MH, Polinsky RJ (1984) Disposition and metabolism of MHPG in humans: Application to studies in depression. Pharmacopsychiatry 17:3–8

    Google Scholar 

  • Larochelle P, Hamet P, Enjalbert M (1979) Responses to tyramine and norepinephrine after imipramine and trazodone. Clin Pharmacol Ther 26(1):24–30

    Google Scholar 

  • Leckman JF, Maas JW, Heninger GR (1981) Covariance of plasma free 3-methoxy-4-hydroxyphenylethyleneglycol and diastolic blood pressure. Eur J Pharmacol 70:111–120

    Google Scholar 

  • Leckman JF, Maas JW (1984) Plasma MHPG: Relationship to brain noradrenergic systems and emerging clinical applications. In: Post RM, Ballenger JC (eds) Neurobiology of mood disorders. Baltimore, Williams & Wilkins, pp 529–538

    Google Scholar 

  • Leckman JF, Maas JW, Redmond DE Jr, Heninger GR (1980) Effects of oral clonidine on plasma 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG) in man: Preliminary report. Life Sci 26:2179–2185

    Google Scholar 

  • Maas JW, Hattox SE, Landis DH, Roth RH (1976) The determination of a brain arteriovenous difference for 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG). Brain Res 118:167–173

    Google Scholar 

  • Maggi A, U'Prichard DC, Enna SJ (1980) Differential effects of antidepressant treatment on brain monoaminergic receptors. Eur J Pharmacol 61:91–98

    Google Scholar 

  • Maj J, Palider W, Rawlow A (1979) Trazodone, a central serotonin antagonist and agonist. J Neural Transm 44:237–248

    Google Scholar 

  • Matussek N, Ackenheil M, Hippius H, Muller F, Shroder H-Th, Schultes H, Wasilewski B (1980) Effects of clonidine on growth hormone release in psychiatric patients and controls. Psychiatr Res 2:25–36

    Google Scholar 

  • McWilliam JR, Meldrum BS (1983) Noradrenergic regulation of growth hormone secretion in the baboon. Endocrinology 112:234–239

    Google Scholar 

  • Nassif S, Kempf E, Cardo B, Velley L (1983) Neurochemical lesion of the locus coeruleus of the rat does not suppress the sedative effect of clonidine. Eur J Pharmacol 91:69–76

    Google Scholar 

  • Passarelli F, Scotti DeCarolis A (1983) Effects of chronic treatment with imipramine, trazodone and electroshock on the behavioural and electroencephalographic modifications induced by clonidine in the rat. Neuropharmacology 22(6):785–789

    Google Scholar 

  • Peterson SL, Napier TC, Rigdon GC, Pirch JH (1983) Dissimilar responses of cortical neurons to chronic trazodone or desipramine treatment. Prog Neuro-Psychopharmacol Biol Psychiatry 7:175–181

    Google Scholar 

  • Riblet IA, Gatewood CF, Mayol RF (1979) Comparative effects of trazodone and tricyclic antidepressants on uptake of selected neurotransmitters by isolated rat brain synaptosomes. Psychopharmacology 63:99–101

    Google Scholar 

  • Riblet LA, Taylor DP (1981) Pharmacology and neurochemistry of trazodone. J Clin Psychopharmacol 1 [Suppl]:17–22S

    Google Scholar 

  • Richardson JS, Chiu EKY (1982) The acute effects of amitriptyline, iprindole and trazodone on blood pressure and heart rate in rats. Pharmacol Biochem Behav 17:1221–1223

    Google Scholar 

  • Richelson E, Pfenning M (1984) Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: Most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 104:277–286

    Google Scholar 

  • Rowbotham MD, Jones RT, Benowitz NL, Jacob P (1984) Trazodone-oral cocaine interactions. Arch Gen Psychiatry 41:895–899

    Google Scholar 

  • Schalch DS, Parker ML (1964) A sensitive double antibody immunoassay for human growth hormone in plasma. Nature 263:1141–1142

    Google Scholar 

  • Scuvee-Moreau J, Dresse A (1982) Effect of trazodone on the firing rate of central monoaminergic neurons. Comparison with various antidepressants. Arch Int Pharmacody 260:299–301

    Google Scholar 

  • Siever LJ, Uhde TW, Insel TR, Roy BF, Murphy DL (1982a) Growth hormone response to clonidine unchanged by chronic clorgyline treatment. Psychiatr Res 7:139–143

    Google Scholar 

  • Siever LJ, Uhde TW, Murphy DL (1982b) Possible subsensitization of alpha-2 adrenergic receptors by chronic monoamine oxidase inhibitor treatment in psychiatric patients. Psychiatr Res 6:293–302

    Google Scholar 

  • Siever LJ, Uhde TW, Silberman EK, Jimerson DC, Aloi JA, Post RM, Murphy DL (1982c) The growth hormone response as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls. Psychiatr Res 6:171–183

    Google Scholar 

  • Stefanini E, Fadda F, Medda L, Gessa GL (1976) Selective inhibition of serotonin uptake by trazodone, a new antidepressant agent. Life Sci 18:1459–1466

    Google Scholar 

  • Stone EA (1983) Problems with current catecholamine hypotheses of antidepressant agents: Speculations leading to a new hypothesis. Behav Brain Sci 6:535–577

    Google Scholar 

  • Strombom U, Svensson TH (1980) Clonidine: attenuation of sedative action by facilitated central noradrenergic neurotransmission. J Neural Transm 47:29–39

    Google Scholar 

  • Sugrue MF (1983a) Chronic antidepressant therapy and associated changes in central monoaminergic receptor functioning. Pharmacol Ther 21:1–33

    Google Scholar 

  • Sugrue MF (1983b) Some effects of chronic antidepressant treatments on rat brain monoaminergic systems. J Neural Transm 57:281–295

    Google Scholar 

  • Sulser F (1984) Regulation and function of noradrenaline receptor systems in brain. Neuropharmacology 23 (2B):255–261

    Google Scholar 

  • Tempesta E, Janiri L, Salera P (1984) The effects of microiontophoretically applied trazodone on single neurones in the rat brain-stem. Drug Res 34(1):157–160

    Google Scholar 

  • Terry LC, Martin JB (1981) Evidence for alpha-adrenergic regulation of episodic growth hormone and prolactin secretion in the undisturbed male rat. Endocrinology 108:1869–1873

    Google Scholar 

  • Timmermans PBMWM, Schoop AMC, Kwa HY, van Zwieten PA (1981) Characterization of the alpha-adrenoceptors participating in the central hypotensive and sedative effects of clonidine using yohimbine, rauwolscine, and coryanthine. Eur J Pharmacol 70:7–16

    Google Scholar 

  • Unnerstall JR, Kopajtic TA, Kuhar MJ (1984) Distribution of α2 agonist binding sites in the rat and human central nervous system: Analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents. Brain Res Rev 7:69–101

    Google Scholar 

  • van Zwieten PA (1977) Inhibition of the central hypotensive effect of clonidine by trazodone, a novel antidepressant. Pharmacology 15:331–336

    Google Scholar 

  • Zavadil AP, Ross RJ, Calil HM, Linnoila M, Blombery P, Jimerson DC, Kopin IJ, Potter WZ (1984) The effect of desmethylimipramine on the metabolism of norepinephrine. Life Sci 35:1061–1068

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Price, L.H., Charney, D.S. & Heninger, G.R. Effects of trazodone treatment on alpha-2 adrenoceptor function in depressed patients. Psychopharmacology 89, 38–44 (1986). https://doi.org/10.1007/BF00175186

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00175186

Key words

Navigation